Analysts See $0.38 EPS for Natus Medical Inc (BABY)

September 17, 2017 - By Marie Mckinney

 Analysts See $0.38 EPS for Natus Medical Inc (BABY)
Investors sentiment increased to 1.93 in Q4 2016. Its up 0.82, from 1.11 in 2016Q3. It is positive, as 11 investors sold Natus Medical Inc shares while 56 reduced holdings. 51 funds opened positions while 78 raised stakes. 29.10 million shares or 6.34% more from 27.36 million shares in 2016Q3 were reported.
Eagle Asset Mgmt holds 0.35% of its portfolio in Natus Medical Inc (NASDAQ:BABY) for 1.51 million shares. Motley Fool Wealth Mgmt Ltd Co accumulated 78,509 shares or 0.29% of the stock. Price T Rowe Assocs Md has invested 0% of its portfolio in Natus Medical Inc (NASDAQ:BABY). Point72 Asset Management Ltd Partnership has 74,900 shares. Jane Street Group Inc Limited Liability Corp holds 0% or 22,647 shares in its portfolio. Kcg reported 13,426 shares. Dimensional Fund Ltd Partnership has 0.02% invested in Natus Medical Inc (NASDAQ:BABY). Dana Invest Advisors Incorporated holds 0.09% or 51,971 shares. Federated Invsts Inc Pa stated it has 1,843 shares. 500,239 are held by Northern Tru. Anderson Hoagland Com reported 0.57% stake. Advsrs Asset Mgmt owns 0.05% invested in Natus Medical Inc (NASDAQ:BABY) for 79,380 shares. Goldman Sachs Gru invested 0% of its portfolio in Natus Medical Inc (NASDAQ:BABY). Petrus Tru Lta stated it has 14,216 shares or 0.12% of all its holdings. Pennsylvania-based Alphaone Llc has invested 0.96% in Natus Medical Inc (NASDAQ:BABY).

Since May 25, 2017, it had 2 buys, and 1 sale for $175,360 activity. $163,400 worth of stock was sold by Engibous Doris on Thursday, May 25.

Analysts expect Natus Medical Inc (NASDAQ:BABY) to report $0.38 EPS on October, 18.They anticipate $0.01 EPS change or 2.56 % from last quarter’s $0.39 EPS. BABY’s profit would be $12.56 million giving it 23.09 P/E if the $0.38 EPS is correct. After having $0.34 EPS previously, Natus Medical Inc’s analysts see 11.76 % EPS growth. The stock decreased 1.40% or $0.5 on September 15, reaching $35.1. About 310,860 shares traded. Natus Medical Inc (NASDAQ:BABY) has risen 4.38% since September 17, 2016 and is uptrending. It has underperformed by 12.32% the S&P500.

Natus Medical Inc (NASDAQ:BABY) Ratings Coverage

Among 4 analysts covering Natus Medical (NASDAQ:BABY), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Natus Medical had 9 analyst reports since July 23, 2015 according to SRatingsIntel. The rating was initiated by Benchmark with “Buy” on Tuesday, October 4. On Thursday, October 22 the stock rating was maintained by TH Capital with “Buy”. Roth Capital maintained the shares of BABY in report on Monday, September 11 with “Buy” rating. The firm has “Mkt Perform” rating by Raymond James given on Thursday, February 2. The firm earned “Buy” rating on Thursday, July 23 by TH Capital. The company was upgraded on Tuesday, September 13 by Raymond James. The firm earned “Buy” rating on Friday, June 23 by Roth Capital. The rating was maintained by TH Capital on Tuesday, January 12 with “Buy”. The firm has “Buy” rating given on Tuesday, April 5 by Roth Capital.

Natus Medical Incorporated is a provider of newborn care and neurology healthcare services and products used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The company has market cap of $1.16 billion. The Company’s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn’s environment, and software systems for managing and tracking disorders and diseases for public health laboratories. It has a 61.62 P/E ratio.

More notable recent Natus Medical Inc (NASDAQ:BABY) news were published by: Fool.com which released: “Natus Medical Incorporated in 4 Charts” on December 05, 2016, also Nasdaq.com with their article: “Natus Medical Inc (BABY) President and CEO James B Hawkins Bought $135920 of …” published on June 16, 2017, Nasdaq.com published: “Eos Focused Equity Management, LP Buys Univar Inc, Natus Medical Inc, General …” on August 08, 2017. More interesting news about Natus Medical Inc (NASDAQ:BABY) were released by: Fool.com and their article: “Natus Medical results: The raw numbers” published on July 27, 2017 as well as Fool.com‘s news article titled: “Why Natus Medical Inc. Sank Today” with publication date: April 26, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.